1
Participants
Start Date
November 15, 2021
Primary Completion Date
December 16, 2022
Study Completion Date
January 16, 2023
microfracture surgery + HST003
This is an Intervention Model where all patients who are identified/confirmed candidates for microfracture surgery will be enrolled to receive the microfracture surgery (standard of care). Ten (10) patients will be randomized to receive the study intervention (HST003). HST003 will be injected into the microfracture defects (interstices) and fill the remainder of the defect to the cartilage margin following surgery. The primary purpose of the study is to compare the two groups: microfracture surgery + HST003 as compared to the microfracture surgery only group.
Site 005, State College
Site 001, Bethesda
Site 003, Bradenton
Site 004, Houston
Site 002, Vail
Lead Sponsor
United States Department of Defense
FED
Histogen
INDUSTRY